377 results
8-K
EX-99.1
WINT
Windtree Therapeutics Inc
17 Apr 24
Windtree Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Key Business Updates
7:30am
include: the Company’s ability to secure significant additional capital as and when needed; the Company’s ability to achieve the intended benefits
8-K
EX-10.1
WINT
Windtree Therapeutics Inc
8 Apr 24
Entry into a Material Definitive Agreement
4:33pm
incurred on behalf of the Company, and (iii) for other standard employee benefits made generally available to all employees or executives (including stock … are in compliance with all federal, state, local and foreign laws and regulations respecting labor, employment and employment practices and benefits, terms
8-K
EX-2.1
pwcn2q
8 Apr 24
Entry into a Material Definitive Agreement
4:33pm
8-K
EX-4.1
h8bago gir5q6z8g
8 Apr 24
Entry into a Material Definitive Agreement
4:33pm
8-K
EX-3.1
6rp 7nt6qfec
8 Apr 24
Entry into a Material Definitive Agreement
4:33pm
8-K
EX-10.2
b3q02wj2 dni1
8 Apr 24
Entry into a Material Definitive Agreement
4:33pm
8-K
EX-10.2
6doo7wa vegbvfznunul
25 Jan 24
Entry into a Material Definitive Agreement
8:34am
8-K
EX-10.1
oekh0vo
25 Jan 24
Entry into a Material Definitive Agreement
8:34am
8-K
EX-1.1
nnnhp 98z
9 Nov 23
Windtree Therapeutics Reports Third Quarter 2023 Financial Results and Provides Key Business Updates
4:21pm
424B5
qaj4mx 63
9 Nov 23
Prospectus supplement for primary offering
4:11pm
8-K
EX-99.1
lvo9rk shyrak
7 Aug 23
Windtree Therapeutics Reports Second Quarter 2023 Financial Results and Provides Key Business Updates
4:02pm